Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis

Table 2 Predictors for BSI due to MRSA in cancer patients

Study	Type of analysis	Predictor	Prevalence (%)	OR (95% CI)	P
Bello-Chavolla et al. 2018 [52]	Multivariate analysis	Hospital-acquired infection	56 (58.9)	5.54 (3.27–9.38)	< 0.001
		Healthcare-associated pneumonia	19 (20.0)	3.02 (1.63–5.59)	< 0.001
		Diabetes mellitus	67 (18.9)	2.09 (1.02–4.28)	0.049
Kang et al. 2012 [13]	Univariate analysis	Nosocomial acquisition	45 (76.3)	3.11 (1.43–6.77)	0.004
		Indwelling urinary catheter	25 (42.4)	3.90 (1.67–9.12)	0.001
		Nasogastric tube	12 (20.3)	5.11 (1.36–19.14)	0.009
		ICU admission	17 (28.8)	4.70 (1.61–13.73)	0.003
Srinivasan et al. 2010 [51]	Chi-square test	Persistently positive blood cultures	5 (50)		0.004
Srinivasan et al. 2010 [51]	Chi-square test	Catheter removal	6 (60)		0.003

BSI bloodstream infections, MRSA Methicillin-resistant Staphylococcus aureus, OR odds ratio, CI confidence interval, ICU intensive care unit

ISSN: 1471-2334